Influenza Inactive Virus Vaccine With the Fusion Peptide (rTα1- BP5) Enhances Protection Against Influenza Through Humoral and Cell-Mediated Immunity

doi 10.5772/64403

Full Text

Abstract

Available in

Date

October 26, 2016

Authors

Publisher

InTech

Related search

Maternal Immunity Against Avian Influenza H5N1 in Chickens: Limited Protection and Interference With Vaccine Efficacy

English

Structural Biology of the Influenza Virus Fusion Peptide.

Acta Biochimica Polonica

English

Evaluation of Humoral and Cell-Mediated Immunity of Two Capripoxvirus Vaccine Strains Against Lumpy Skin Disease Virus

Iranian Journal of Virology

2016

English

Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection Against Lethal Influenza a H5N1 Virus Infection

English

Infection of Influenza Virus Neuraminidase-Vaccinated Mice With Homologous Influenza Virus Leads to Strong Protection Against Heterologous Influenza Viruses

Journal of General Virology

Virology

2014

English

The Anti-Influenza Virus Agent 4-Gu-Dana (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA

English

Cross-Protective Immunity Against Influenza a/H1n1 Virus Challenge in Mice Immunized With Recombinant Vaccine Expressing HA Gene of Influenza a/H5n1 Virus

English

Reconstructed H3N2 Influenza Virus Predicted From Influenza Vaccine Strains Improved Cross-Protective Immunity in Mice

African Journal of Microbiology Research

2016

English

Innovative Mucosal Vaccine Formulations Against Influenza a Virus Infections

Frontiers in Immunology

Allergy

Immunology

2019

Italian

Amanote Research

Influenza Inactive Virus Vaccine With the Fusion Peptide (rTα1- BP5) Enhances Protection Against Influenza Through Humoral and Cell-Mediated Immunity

Full Text

Abstract

Date

Authors

Publisher

Related search

Maternal Immunity Against Avian Influenza H5N1 in Chickens: Limited Protection and Interference With Vaccine Efficacy

Structural Biology of the Influenza Virus Fusion Peptide.

Evaluation of Humoral and Cell-Mediated Immunity of Two Capripoxvirus Vaccine Strains Against Lumpy Skin Disease Virus

Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection Against Lethal Influenza a H5N1 Virus Infection

Infection of Influenza Virus Neuraminidase-Vaccinated Mice With Homologous Influenza Virus Leads to Strong Protection Against Heterologous Influenza Viruses

The Anti-Influenza Virus Agent 4-Gu-Dana (Zanamivir) Inhibits Cell Fusion Mediated by Human Parainfluenza Virus and Influenza Virus HA

Cross-Protective Immunity Against Influenza a/H1n1 Virus Challenge in Mice Immunized With Recombinant Vaccine Expressing HA Gene of Influenza a/H5n1 Virus

Reconstructed H3N2 Influenza Virus Predicted From Influenza Vaccine Strains Improved Cross-Protective Immunity in Mice

Innovative Mucosal Vaccine Formulations Against Influenza a Virus Infections